Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Quidelortho Corp (NQ: QDEL ) 37.32 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 13, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Quidelortho Corp < Previous 1 2 ... 9 10 11 12 13 14 15 16 Next > The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case December 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir... Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property Quidel Statement on the Omicron Variant November 30, 2021 From Quidel Corporation Via Business Wire Biotech Stocks are Due for a Rally November 22, 2021 There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums. Via Talk Markets Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference November 19, 2021 From Quidel Corporation Via Business Wire Looking for Growth in Small and Mid Cap Life Science Stocks November 15, 2021 2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps. Via Talk Markets Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations November 09, 2021 FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – New at-home Covid tests are on the way, according to the Biden administration, which announced... Via FinancialNewsMedia Exposures COVID-19 Quidel Corp (QDEL) Q3 2021 Earnings Call Transcript November 05, 2021 QDEL earnings call for the period ending October 4, 2021. Via The Motley Fool Topics Earnings Exposures Financial Quidel Reports Third Quarter 2021 Financial Results November 04, 2021 From Quidel Corporation Via Business Wire The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation November 02, 2021 Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation Via News Direct Exposures COVID-19 Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation November 02, 2021 From Quidel Corporation Via Business Wire Quidel to Hold Fiscal Third Quarter 2021 Financial Results Conference Call on November 4th, 2021 October 20, 2021 From Quidel Corporation Via Business Wire Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead October 20, 2021 FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 20, 2021 – USA News Group – It may have its beginning for the UK travel industry, but there are signs of the end of using... Via FinancialNewsMedia Exposures COVID-19 Pediatric Lyme Disease—‘An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21 October 18, 2021 From Quidel Corporation Via Business Wire The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21 October 18, 2021 Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21 Via News Direct Exposures COVID-19 Product Safety Quidel Blows Past Estimates for Q3 Revenue October 14, 2021 COVID-19 testing volumes are up again. Via The Motley Fool Exposures COVID-19 Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected October 08, 2021 Quidel Corporation (NASDAQ: QDEL) announced preliminary estimates for its Q3 revenues are expected to rise between 6% and 7% Y/Y on COVID-19 assay sales. Related:... Via Benzinga Exposures COVID-19 After the Jobs Report, Investors are Looking at The Fed for Tapering Signals October 08, 2021 Investors were in wait-and-see mode before the Employment Situation Report and then the volatility hit. Non-farm job growth was expected to be around 500,000... Via Benzinga Topics Economy Exposures Interest Rates The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs October 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Exposures Product Safety A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Data October 08, 2021 Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade ahead of the all-important jobs report for the month of September. Analysts expect nonfarm... Via Benzinga 5 Stocks To Watch For October 8, 2021 October 08, 2021 Some of the stocks that may grab investor focus today are: At its annual shareholder meeting, Tesla Inc’s (NASDAQ: TSLA) CEO Elon Musk announced plans to move its... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session October 07, 2021 Gainers Vaxart (NASDAQ:VXRT) shares incr... Via Benzinga Quidel Announces Preliminary Revenue for Fiscal Third Quarter 2021 October 07, 2021 From Quidel Corporation Via Business Wire Employer Demand For Rapid COVID-19 Tests Deepen Shortage In US: Reuters October 06, 2021 In recent weeks, an increase in demand for COVID-19 tests from U.S. employers has deepened the shortage of rapid tests and is driving up testing programs costs. What Happened: The... Via Benzinga Exposures COVID-19 2 Growth Stocks to Buy if You're Worried COVID Is Here to Stay October 02, 2021 These could be good hedges to help offset the pandemic-related risks. Via The Motley Fool Exposures COVID-19 Biotech Playbook Revisited As Technicals Weaken September 27, 2021 Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still... Via Talk Markets FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations September 24, 2021 The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19... Via Benzinga Exposures COVID-19 Product Safety Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates September 14, 2021 Via FinancialNewsMedia Exposures COVID-19 Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market September 09, 2021 Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day. Via Talk Markets < Previous 1 2 ... 9 10 11 12 13 14 15 16 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.